Roche plans to expand and upgrade its manufacturing facilities at its headquarters in Basel, Switzerland, as part of the company’s ongoing efforts to expand its biologics manufacturing network.   The company plans to invest approximately $135 million to build new facilities at its Basel headquarters and upgrade existing production operations, including a new facility for small-molecules, which is expected to be operational by 3Q16, and the expansion of an existing facility for investigational dr...